A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection.
about
Delivery of oligonucleotides with lipid nanoparticlesFimH adhesin of type 1 fimbriae is a potent inducer of innate antimicrobial responses which requires TLR4 and type 1 interferon signalling.Immunostimulatory and anti-neoplasm effects of a novel palindrome CpG oligodeoxynucleotide in mice.Defective plasmacytoid dendritic cell-NK cell cross-talk in HIV infection.NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infectionNasolacrimal duct closure modulates ocular mucosal and systemic CD4(+) T-cell responses induced following topical ocular or intranasal immunization.Deoxycytidyl-deoxyguanosine oligonucleotide classes A, B, and C induce distinct cytokine gene expression patterns in rhesus monkey peripheral blood mononuclear cells and distinct alpha interferon responses in TLR9-expressing rhesus monkey plasmacytoCharacterization of human immunodeficiency virus Gag-specific gamma interferon-expressing cells following protective mucosal immunization with alphavirus replicon particles.Expression of type III interferon (IFN) in the vaginal mucosa is mediated primarily by dendritic cells and displays stronger dependence on NF-kappaB than type I IFNs.RNA-dependent protein kinase is required for alpha-1 interferon transgene-induced resistance to genital herpes simplex virus type 2.Prevention and treatment of cutaneous leishmaniasis in primates by using synthetic type D/A oligodeoxynucleotides expressing CpG motifs.The Toll-like receptor 7 (TLR7) agonist, imiquimod, and the TLR9 agonist, CpG ODN, induce antiviral cytokines and chemokines but do not prevent vaginal transmission of simian immunodeficiency virus when applied intravaginally to rhesus macaques.Enhancing mucosal immunity in mice by recombinant adenovirus expressing major epitopes of porcine circovirus-2 capsid protein delivered with cytosine-phosphate-guanosine oligodeoxynucleotidesLoss of the type I interferon pathway increases vulnerability of mice to genital herpes simplex virus 2 infection.Coordination of early protective immunity to viral infection by regulatory T cellsLambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo.Mucosal administration of CpG oligodeoxynucleotide elicits strong CC and CXC chemokine responses in the vagina and serves as a potent Th1-tilting adjuvant for recombinant gD2 protein vaccination against genital herpesA crucial role for plasmacytoid dendritic cells in antiviral protection by CpG ODN-based vaginal microbicideOrally administered CpG oligodeoxynucleotide induces production of CXC and CC chemokines in the gastric mucosa and suppresses bacterial colonization in a mouse model of Helicobacter pylori infectionInduction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.Quantification of poly(I:C)-mediated protection against genital herpes simplex virus type 2 infection.Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2.Innate and adaptive immune responses to herpes simplex virusEvasion of early antiviral responses by herpes simplex viruses.Molecular adjuvants for mucosal immunity.A genital tract peptide epitope vaccine targeting TLR-2 efficiently induces local and systemic CD8+ T cells and protects against herpes simplex virus type 2 challengeAdvances in mucosal vaccination.Stimulation with a class A CpG oligonucleotide enhances resistance to infection with feline viruses from five different familiesPreinfection treatment of resistant mice with CpG oligodeoxynucleotides renders them susceptible to friend retrovirus-induced leukemiaToll-like receptors in the gonads and reproductive tract: emerging roles in reproductive physiology and pathology.Salmonella enterica serovar typhimurium exploits Toll-like receptor signaling during the host-pathogen interaction.FSL-1, a bacterial-derived toll-like receptor 2/6 agonist, enhances resistance to experimental HSV-2 infection.Amphipathic DNA polymers exhibit antiviral activity against systemic murine Cytomegalovirus infection.CpG oligodeoxynucleotides block human immunodeficiency virus type 1 replication in human lymphoid tissue infected ex vivo.Herpes simplex virus and human papillomavirus genital infections: new and investigational therapeutic options.Induction of innate immune responses in the female genital tract: friend or foe of HIV-1 infection?Sensing herpes: more than toll.Type I interferons in regulation of mucosal immunity.Interferons as biomarkers and effectors: lessons learned from animal models.TLR Agonists as Modulators of the Innate Immune Response and Their Potential as Agents Against Infectious Disease.
P2860
Q27024646-EAEE27C5-E7E4-40FB-AFED-10DC50CA9AFCQ33389846-5417FC97-2F29-4315-A8F3-6CD8029E30D7Q33571317-C428CACA-C3F3-4B6F-8A6D-06AE937CBCE9Q33686528-30AD04BA-9CBC-4506-AC20-BC2B2038CE25Q33707533-90253417-7342-4775-8C47-E36AE2A1C917Q33725145-CC958F88-0714-48EA-B4D0-CA93B80D14B7Q33788621-FEFC07B5-139A-4AFB-8007-51CE9E18C04AQ33788861-7AF65EC4-B459-4B6D-BDF2-A24206C4CC18Q33826704-13BB2242-9A9B-4E43-B3F3-D715BB5D365AQ33883922-1ACB2BED-1AD2-43B1-B927-7169BFBEB054Q33946716-AD57E62A-6629-4414-BB80-3258E35718EFQ34124090-04F3B71B-74C6-487A-8688-0C8139A41A76Q34258568-E548CDA9-901F-4F18-9D01-C9379727BD12Q34529742-3AD52217-9FF8-45B8-9622-B0DA5A328B05Q34591024-8E3AB7B3-ADDF-4D4D-98A9-EC683B9DED45Q34647423-5AD0F479-46FE-4E8E-96CA-E95DD07F4285Q34648207-4F1F1DED-76D9-47AA-A0FD-01628D4A4CFAQ34830678-656BBDA9-9900-430D-87D6-2B7BEFE3AC2BQ34941937-7EB073EB-AEAD-4916-8521-BFF6996C7132Q35101507-C1CB10F6-BF70-4402-A699-52722475E026Q35101552-DD94A4C4-0E0C-4566-8EF9-2EC288E3E42EQ35182216-395A3844-497D-482E-B93B-6FDD72278F92Q35260078-40A56FE7-D993-40B3-917B-8B96BE6C11FDQ35414669-C0E62D47-06A2-4EBE-8611-9B3742C134B5Q35826381-E33570BC-8506-431A-880F-EEDE1E524980Q35871689-A14CD62D-664F-4880-A18E-FAF70F6E592DQ36177348-5527F5E7-1A8A-406F-B992-1D5783898CCEQ36510121-6825FA10-4D45-4ADB-85F9-2E5DFFDA81D8Q36525130-450CD303-4567-493E-A6E0-0ACEC57CA0F5Q36860597-2B1C0F34-75CB-4596-BA89-AC8DB14F0C1CQ37410335-34D49961-3913-420D-BE3D-50717F955160Q37428262-7B7F74A4-C73F-49BA-9ABD-4E4BFC486AC6Q37477905-50298C1D-55A5-4C76-B5D6-BD084751FF66Q37596720-F06D54AD-D028-4835-8A2A-D9604DB640D8Q37771396-23E2F2BE-13B0-4A11-88B3-20792A0D6FABQ37827571-BA7427C1-D9CA-4FEA-9BD0-49D724BAEE3BQ37948677-E4244D57-4797-4400-BB10-31A1683D1F2CQ37994985-C87812DA-1FD0-4D09-9F87-AAA413999B0FQ37997045-D6A2EC37-465A-4FF8-A440-6847E39CAAEAQ38195597-FF18F234-59C5-4C84-AB17-DEB693947E51
P2860
A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
A protective role of locally a ...... l of genital herpes infection.
@ast
A protective role of locally a ...... l of genital herpes infection.
@en
A protective role of locally a ...... l of genital herpes infection.
@nl
type
label
A protective role of locally a ...... l of genital herpes infection.
@ast
A protective role of locally a ...... l of genital herpes infection.
@en
A protective role of locally a ...... l of genital herpes infection.
@nl
prefLabel
A protective role of locally a ...... l of genital herpes infection.
@ast
A protective role of locally a ...... l of genital herpes infection.
@en
A protective role of locally a ...... l of genital herpes infection.
@nl
P2860
P1433
P1476
A protective role of locally a ...... l of genital herpes infection.
@en
P2093
Ali M Harandi
Kristina Eriksson
P2860
P304
P356
10.1128/JVI.77.2.953-962.2003
P407
P50
P577
2003-01-01T00:00:00Z